EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunological Safety Evaluation of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells in Mice

Cancan Wang iD, Xinmei Hu, Yu Liu, Yu Xiao, Peng Jiang, Yunjing Lin, Xiaomin Liu, Zhengmian Zhang iD, Liang-Cheng Li iD, Zhongquan Qi iD

Stem Cells International · 2025-01 · 2025 (1)

DOI: 10.1155/sci/9986368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells International, online erschienen am 26.04.2025. Verfasst von Cancan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, Guangxi Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mounting evidence indicates that exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs‐exosomes) combine the advantages of hucMSC pluripotency with their nanoscale dimensions, enhancing their clinical potential through prolonged circulation half‐life. Despite these promising characteristics, research on their immunological toxicity remains insufficient. This study focuses on the impact of hucMSC‐exosomes on the general toxicity and immunopathological indicators. When mice received tail vein injections of 6 × 10 10 hucMSC‐exosomes particles, we observed no significant changes in body weight, feed intake, blood composition, organ indices, or histopathological findings throughout the 14 days observation period. Similarly, blood levels of immunoglobulins, cytokines, and lymphocyte subpopulations remained stable. The hucMSC‐exosomes produced no detectable negative effects on immune organs including the thymus, spleen, and bone marrow. These findings indicate that intravenous administration of 6 × 10 10 particles of hucMSC‐exosomes appears relatively safe at the murine level. This assessment of safety and immunological impact following intravenous hucMSC‐exosomes infusion offers experimental support for potential clinical applications and future analyses in this field.

Schlagwörter

Stichwörter der Autor:innen

effectsexosomesgeneral toxicityhucMSCimmunotoxicitysafety evaluationtail vein injection administration

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China.
  • Fujian Provincial Sperm Bank, Fujian Maternity and Child Health Hospital, Fuzhou 350001, China.
  • School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China.

ORCID-Profile: Cancan Wang, Zhengmian Zhang, Liang-Cheng Li, Zhongquan Qi

Förderung

  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • Guangxi Key Research and Development Program

Zitieren

APA

Wang, C., Hu, X., Liu, Y., Xiao, Y., Jiang, P., Lin, Y., Liu, X., Zhang, Z., Li, L. C., & Qi, Z. (2025). Immunological Safety Evaluation of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells in Mice. Stem Cells International, 2025(1). https://doi.org/10.1155/sci/9986368

Vancouver

Wang C, Hu X, Liu Y, Xiao Y, Jiang P, Lin Y, et al. Immunological Safety Evaluation of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells in Mice. Stem Cells International. 2025;2025(1). doi:10.1155/sci/9986368

BibTeX
@article{Wang2025,
  author = {Wang, Cancan and Hu, Xinmei and Liu, Yu and Xiao, Yu and Jiang, Peng and Lin, Yunjing and Liu, Xiaomin and Zhang, Zhengmian and Li, Liang-Cheng and Qi, Zhongquan},
  title = {Immunological Safety Evaluation of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells in Mice},
  journal = {Stem Cells International},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/sci/9986368}
}
Kostenlos starten →